SEC Info - Ibex Investors LLC, et al. - ‘4’ for 6/18/20 re: Aeon Global Health Corp.

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Ibex Investors LLC

(Last)

(First)

(Middle)

260 N. JOSEPHINE STREET, SUITE 300

(Street)

DENVER

80206

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Aeon Global Health Corp. [ AGHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
6/18/20

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	6/18/20		S		9,889	D	$0.07	448,244 ⁽⁴⁾	I	By: Ibex Microcap Fund LLLP ⁽¹⁾ ⁽³⁾
Common Stock	6/18/20		S		184,000	D	$0.061	264,244	I	By: Ibex Microcap Fund LLLP ⁽¹⁾ ⁽³⁾
Common Stock	6/18/20		S		23,129	D	$0.0601	241,115	I	By: Ibex Microcap Fund LLLP ⁽¹⁾ ⁽³⁾
Common Stock	6/18/20		S		46,871	D	$0.06	194,244	I	By: Ibex Microcap Fund LLLP ⁽¹⁾ ⁽³⁾
Common Stock	6/19/20		S		5,000	D	$0.07	189,244	I	By: Ibex Microcap Fund LLLP ⁽¹⁾ ⁽³⁾
Common Stock	6/19/20		S		2,500	D	$0.065	186,744	I	By: Ibex Microcap Fund LLLP ⁽¹⁾ ⁽³⁾
Common Stock								833	I	By: Lazarus Macro Micro Partners LLLP ⁽²⁾ ⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

1. Name and Address of Reporting Person^*

Ibex Investors LLC

(Last)

(First)

(Middle)

260 N. JOSEPHINE STREET, SUITE 300

(Street)

DENVER

80206

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Ibex Microcap Fund LLLP

(Last)

(First)

(Middle)

260 N. JOSEPHINE STREET, SUITE 300

(Street)

DENVER

80206

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Lazarus Macro Micro Partners LLLP

(Last)

(First)

(Middle)

260 N. JOSEPHINE STREET, SUITE 300

(Street)

DENVER

80206

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

BORUS JUSTIN B

(Last)

(First)

(Middle)

260 N. JOSEPHINE STREET, SUITE 300

(Street)

DENVER

80206

(City)

(State)

(Zip)

Explanation of Responses:

(1) These securities reported herein are owned directly by Ibex Microcap Fund LLLP ("Ibex Microcap"). Ibex Investors LLC ("Ibex") is the investment adviser and general partner of Ibex Microcap and Justin B. Borus is the manager of Ibex.

(2) These securities reported herein are owned directly by Lazarus Macro Micro Partners LLLP ("Macro Micro"). Ibex is the investment adviser and general partner of Macro Micro.

(3) Each of Ibex and Mr. Borus expressly disclaims beneficial ownership of the securities held by Ibex Microcap and Macro Micro (referred to collectively as the "Funds") except to the extent of his or its pecuniary interest therein, if any. Each of the Funds expressly disclaims beneficial ownership of the securities held by the other Fund. The filing of this Form 4 shall not be construed as an admission that either Ibex or Mr. Borus (or each Fund with respect to the securities held by the other Fund), for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.

(4) Includes 5,159 shares of Common Stock issued to Ibex Microcap as dividends on the Series D Convertible Preferred Stock through and including the dividend payment date of December 31, 2018, which acquisition was exempt from the reporting requirements of Section 16 of the Securities Exchange Act of 1934.

	/s/ Justin B. Borus, for himself and as Manager of Ibex (for itself and on behalf of the Funds)	6/22/20
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

____________ Transaction Code:
S	Open market or private sale of non-derivative or derivative security.

Ibex Investors LLC, et al. – ‘4’ for 6/18/20 re: Aeon Global Health Corp.

On: Monday, 6/22/20, at 4:40pm ET · For: 6/18/20 · Accession #: 1079973-20-534 · File #: 0-20190

Previous ‘4’: ‘4’ on 3/23/20 for 3/19/20 · Next: ‘4’ on 7/27/20 for 7/9/20 · Latest: ‘4’ on / for 7/6/21

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Ibex Investors LLC, et al. – ‘4’ for 6/18/20 re: Aeon Global Health Corp.

On: Monday, 6/22/20, at 4:40pm ET · For: 6/18/20 · Accession #: 1079973-20-534 · File #: 0-20190

Previous ‘4’: ‘4’ on 3/23/20 for 3/19/20 · Next: ‘4’ on 7/27/20 for 7/9/20 · Latest: ‘4’ on / for 7/6/21

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents